Cargando…
A molecular glue approach to control the half-life of CRISPR-based technologies
Cas9 is a programmable nuclease that has furnished transformative technologies, including base editors and transcription modulators (e.g., CRISPRi/a), but several applications of these technologies, including therapeutics, mandatorily require precision control of their half-life. For example, such c...
Autores principales: | Sreekanth, Vedagopuram, Jan, Max, Zhao, Kevin T., Lim, Donghyun, Davis, Jessie R., McConkey, Marie, Kovalcik, Veronica, Barkal, Sam, Law, Benjamin K., Fife, James, Tian, Ruilin, Vinyard, Michael E., Becerra, Basheer, Kampmann, Martin, Sherwood, Richard I., Pinello, Luca, Liu, David R., Ebert, Benjamin L., Choudhary, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028966/ https://www.ncbi.nlm.nih.gov/pubmed/36945568 http://dx.doi.org/10.1101/2023.03.12.531757 |
Ejemplares similares
-
Photoswitchable Molecular Glues Enable Optical Control of Transcription Factor Degradation
por: Arp, Christopher J., et al.
Publicado: (2023) -
Engineering designer beta cells with a CRISPR-Cas9 conjugation platform
por: Lim, Donghyun, et al.
Publicado: (2020) -
Chemogenetic System Demonstrates That Cas9 Longevity Impacts Genome Editing Outcomes
por: Sreekanth, Vedagopuram, et al.
Publicado: (2020) -
Large fundal varices: to glue or not to glue?
por: Mohiuddin, Syed Adnan, et al.
Publicado: (2014) -
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
por: Heckl, Dirk, et al.
Publicado: (2014)